Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2025-04-17 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
关于公司2024年度证券与衍生品投资情况的专项报告
Audit Report / Information Classification · 95% confidence The document is a special report on the company's securities and derivatives investment situation for the year 2024. It includes details about approvals, investment amounts, risk analysis, and risk control measures related to foreign exchange hedging activities. The document references compliance with Shenzhen Stock Exchange regulations and includes a sponsor institution's verification opinion. The document is titled as a "special report" and is a standalone disclosure about a specific aspect of the company's financial activities, not a full annual or interim report. It is not an announcement of a report publication but the report itself. This fits the category of Audit Report / Information (AR), as it is a standalone report on a specific financial activity and compliance, not a full annual report or earnings release.
2025-04-17 Chinese
监事会关于2024年限制性股票激励计划首次授予第一个归属期归属名单和预留授予激励对象名单的核查意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board opinion on the 2024 restricted stock incentive plan, specifically regarding the verification of the first grant's vesting list and the reserved grant incentive object list. It references compliance with company law, securities law, stock exchange listing rules, and internal company regulations. The document is a formal opinion or report from the supervisory board rather than a financial report, earnings release, or capital update. It does not contain financial statements or earnings data, nor is it an announcement of voting results or management changes. It is a regulatory compliance-related document concerning stock incentive plans and internal governance. Given its nature and content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory or compliance documents that do not fit other specific categories. The document length is short (1021 characters), and it is not an announcement of a report publication but a substantive regulatory opinion. Therefore, the classification is RNS with high confidence.
2025-04-17 Chinese
东兴证券关于深圳市美好创亿医疗科技股份有限公司2024年度内部控制自我评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2024 of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd., with verification opinions from Dongxing Securities Co., Ltd. It discusses the internal control evaluation scope, methodology, findings, and conclusions, including financial and non-financial internal control defect standards and remediation status. The document is a detailed report on internal control evaluation and verification, not a general annual report or earnings release. It is not a brief announcement or certification but a substantive report on internal control. This fits the category of Audit Report / Information (AR), which includes audit reports and internal control evaluations separate from full annual reports.
2025-04-17 Chinese
关于“质量回报双提升”行动方案的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. regarding the progress of their "Quality and Return Double Improvement" action plan. It discusses business updates, strategic initiatives, R&D investments, investor relations, dividends, and share repurchases. The document is relatively short (2743 characters) and does not contain detailed financial statements or comprehensive financial data. It is primarily an update on company progress and investor relations, including mention of dividends and share buybacks, but it is not a formal earnings release or annual/interim report. It also does not fit into categories like M&A, board changes, or legal proceedings. Given the content and length, this is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2025-04-17 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 13th meeting of the 2nd Supervisory Board of Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. It includes approvals of various reports and proposals related to the 2024 Annual Report, financial statements, profit distribution, internal control, use of funds, stock incentive plans, and other corporate governance matters. The document references the 2024 Annual Report and other reports but does not contain the full reports themselves. It is a formal meeting resolution announcement with voting results and references to disclosures on an external website (cninfo.com.cn). The document length is about 5108 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full annual report or financial report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of supervisory board meeting resolutions and approvals, not the actual annual report or financial statements themselves.
2025-04-17 Chinese
关于召开2024年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items including approval of the 2024 annual report, board and supervisory reports, financial statements, profit distribution, stock incentive plans, and board member elections. It also contains attachments such as proxy forms, registration forms, and legal representative certifications. The document is primarily an announcement and invitation to shareholders to attend and vote at the AGM, rather than the actual annual report or financial statements themselves. The length is about 7,325 characters, which is consistent with a detailed AGM notice. Therefore, the document fits the category of AGM Information (AGM-R).
2025-04-17 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.